Severe Stenosis of Mitral Bioprosthetic Valve Thrombosis in a Patient with HCV-Related Cirrhosis and Duodenal Variceal Bleeding: The Deadly Triad.
Rosangela CocchiaSalvatore ChianeseGiovanni LombardiLuigia RomanoValentina CaponeLucio AmitranoRaffaele BennatoBrigida RanieriGiuseppe RussoCiro MauroEduardo BossonePublished in: Clinics and practice (2022)
Bioprosthetic valve thrombosis (BPVT) is considered a relatively rare but life-threatening clinical entity. Thus, there is the need of high clinical suspicion in order to make a timely diagnosis and related appropriate therapeutic interventions. In this regard, the management of BPVT is high risk, whatever the option taken (surgery and/or systemic fibrinolysis). The presence of severe comorbidities-as decompensated cirrhosis-further complicates the clinical decision-making process, calling for a patient-tailored integrated multidisciplinary approach. We report a challenging case of a 45-year-old patient with mitral bioprosthetic valve thrombosis and hepatitis C virus (HCV)-related cirrhosis complicated by active duodenal variceal bleeding.
Keyphrases
- mitral valve
- aortic valve
- hepatitis c virus
- aortic stenosis
- aortic valve replacement
- left atrial
- transcatheter aortic valve replacement
- left ventricular
- pulmonary embolism
- case report
- human immunodeficiency virus
- transcatheter aortic valve implantation
- decision making
- ejection fraction
- minimally invasive
- early onset
- drug induced
- coronary artery disease
- coronary artery bypass
- percutaneous coronary intervention